A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

NCT01059643 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Non Small Cell Lung Cancer
Prostate Cancer
Colorectal Cancer
Gastric Cancer
Esophageal Cancer
Cancer of Head and Neck

Interventions

DRUG: LY2523355
DRUG: pegfilgrastim

Sponsor

Eli Lilly and Company